Continuous hybridoma growth and monoclonal antibody production in hollow fiber reactors–separators
- 1 May 1986
- journal article
- research article
- Published by Wiley in Biotechnology & Bioengineering
- Vol. 28 (5) , 646-658
- https://doi.org/10.1002/bit.260280503
Abstract
Growth of a hybridoma culture, along with production of monoclonal antibody, was demonstrated over extended periods in polysulfone hollow fiber membrane modules. The molecular weight cutoffs of the membranes were 70,000, 50,000, and 100,000 daltons. The hybridoma cell line, designated 65/26, produced IgG (2b/κ) directed at mouse thymus cell surface antigen, TL.1. Cell growth occurred in the shell space of the reactor, using supplemented RPMI 1640 (20% fetal bovine serum) supplied from a separate reservoir vessel through the hollow fiber lumen. The reservoir contained 125 mL media, which was changed every 4 days. Concentrations of immunoglobulin were determined by an enzyme immunoassay (using protein A and alkaline phosphatase-labeled antibody conjugate). For the 10K, 50K, and 100K hollow fiber membrane modules, the maximum IgG concentrations detected in the 2.5-mL shell space were 47.5–80, 510, and 740 μg/mL, respectively. In the 125-mL reservoir for the 100K hollow fiber membrane module, the IgG concentration was measured at 260 μg/mL These values compare with an IgG concentration of 1 μg/mL when grown in a standard tissue culture flask and 3.2–7.6 μg/mL when grown in 100 ml media in a spinner flask. In addition, 10K and 50K hollow fiber membrane modules were run in a mode that decreased the fetal bovine serum supplement with time. Differences between these systems suggest that it is possible to obtain high IgG accumulation rates, both during and after the exponential growth phase of the hybridoma population.This publication has 15 references indexed in Scilit:
- Hollow Fiber Cell Culture Systems for Economical Cell-Product ManufacturingNature Biotechnology, 1985
- Engineering Tomorrows's VaccinesNature Biotechnology, 1984
- The Industrial Revolution in MonoclonalsNature Biotechnology, 1984
- Celltech Opens New Monoclonal Production FacilityNature Biotechnology, 1983
- Genentech Makes Monoclonal Precursors from E. coliBio/Technology, 1983
- Australian Government Pushes for Biotechnology R&DNature Biotechnology, 1983
- Fine Specificity Analysis with Monoclonal Antibodies of Antigens Controlled by the Major Histocompatibility Complex and by the Qa/TL Region in MiceImmunological Reviews, 1979
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- Hormone production by cells grown in vitro on artificial capillariesExperimental Cell Research, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970